| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
26. November 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
26. November 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
26. November 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
26. November 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
26. November 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
26. November 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
26. November 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
26. November 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
26. November 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
26. November 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
26. November 2024 |
| Sr. Sales Executive-BC |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
19. November 2024 |
| Medical Science Liaison-Oncology-Breast Cancer |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Research & Development |
14. November 2024 |
| (Sr.) Sales Executive-Solid Tumor |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
04. November 2024 |
| (Senior) Medical Advisor (Radioligand Therapy) |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Research & Development |
09. Oktober 2024 |
| Associate Sales Manager |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
18. Juli 2024 |
| (Sr.) Sales Executive-OPH |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
12. Juni 2024 |